The Correlation of Platelet-Monocyte Aggregate Formation and IFITM3 Gene Expression with COVID-19 Severity

AuthorFatemeh Panahien
AuthorMohammad Jafar Sharifien
AuthorNahid Nasirien
AuthorGholamhossein Tamaddonen
OrcidGholamhossein Tamaddon [0000-0001-8158-6004]en
Issued Date2024-10-31en
AbstractBackground: Platelet-leukocyte aggregates have been implicated in various infectious and inflammatory diseases. The Interferon-induced transmembrane protein 3 (IFITM3) protein plays a role in eliminating viral infections, but its role in the severity of COVID-19 is not well understood. Objectives: We aimed to investigate the correlation between IFITM3 mRNA expression and platelet-monocyte complex levels with the severity of COVID-19, as well as various inflammatory and coagulation markers. Methods: We conducted a cross-sectional study on 54 COVID-19 patients, classified into severe and mild/moderate subgroups. Demographics and laboratory findings were extracted from patients' medical records. We measured IFITM3 mRNA expression in patients' buffy coats using q-RT-PCR and used flow cytometry with CD61 and CD14 markers to measure platelet-monocyte aggregates. Results: No significant difference was found in IFITM3 mRNA expression levels or platelet-monocyte complexes between severe and mild/moderate groups (P = 0.067 and P = 0.056). Lymphocyte counts were significantly higher in the mild/moderate subgroup (21.7 ± 8.9 vs 16.3 ± 10.9, P = 0.02), while neutrophil counts were significantly higher in severe patients (78.3 ± 12.2 vs 72.3 ± 9.9, P = 0.01). Additionally, levels of CRP and LDH were significantly higher in severe COVID-19 patients (P = 0.01 and P = 0.001, respectively). A strong positive correlation was observed between the hospitalization period and CRP, CRP with neutrophils and LDH, as well as between O2 saturation and lymphocytes (P < 0.001, P = 0.0003, P = 0.002, and P = 0.005, respectively). Conclusions: Our findings suggest that IFITM3 gene expression and platelet-monocyte aggregate levels do not correlate with disease outcomes in COVID-19. However, further investigations with larger sample sizes are needed to better understand the mechanisms involved. Monitoring inflammatory and coagulation markers remains important for managing COVID-19 patients.en
DOIhttps://doi.org/10.5812/semj-146016en
KeywordCoronavirus Disease 2019 (COVID-19)en
KeywordPlatelet-Monocyte Aggregateen
KeywordInterferon-Inducible Transmembrane Protein 3 (IFITM3)en
KeywordThrombotic Complicationsen
PublisherBrieflandsen
TitleThe Correlation of Platelet-Monocyte Aggregate Formation and IFITM3 Gene Expression with COVID-19 Severityen
TypeResearch Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
semj-25-10-146016-publish-pdf.pdf
Size:
711.65 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF